furosemide norameda 10 mg/ml injekčný/infúzny roztok
uab norameda, litva - furosemid - 50 - diuretica
furosemid fmk 40 mg
farmak international sp. z o.o., poľsko - furosemid - 50 - diuretica
furosemid medreg
medreg s.r.o., Česká republika - furosemid - 50 - diuretica
furosemid kabi 20 mg/2 ml
fresenius kabi s.r.o., Česká republika - furosemid - 50 - diuretica
furosemid hameln 10 mg/ml injekčný roztok
hameln pharma gmbh, nemecko - furosemid - 50 - diuretica
furosemid-slovakofarma forte
zentiva a.s., slovensko - furosemid - 50 - diuretica
furosemid-slovakofarma
zentiva a.s., slovensko - furosemid - 50 - diuretica
furosemid bbp 10 mg/ml
bb pharma a.s., Česká republika - furosemid - 50 - diuretica
furosemid bbp 12,5 mg/ml
bb pharma a.s., Česká republika - furosemid - 50 - diuretica
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakteriálne pre systémové použitie, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. je treba vziať do úvahy oficiálne usmernenie o vhodnom používaní antibakteriálne agentov.